NCT04542135 2025-06-03
Sulindac and Breast Density in Women at Risk of Developing Breast Cancer
Stony Brook University
Phase 2 Completed
Clinical Trials
6 trialsNCT01515137 2023-03-28
Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma
University of Pittsburgh
Phase 1 Completed
NCT01761877 2023-02-10
NSAID Effects on Clinical and Imaging Breast Biomarkers
Stony Brook University
Phase 2 Completed
NCT00299195 2020-11-19
A Randomized Study of Sulindac in Oral Premalignant Lesions
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01187901 2016-06-17
FAPEST
University of Utah
Phase 2 Completed
NCT00039520 2014-05-06
Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer
Fox Chase Cancer Center
Phase 2 Completed